From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.06
First Reported 2003
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.74
Pain Relevance 0.37

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (ENPP3)
ENPP3 (Homo sapiens)
Pain Link Frequency Relevance Heat
cva 50 99.88 Very High Very High Very High
adenocard 3 98.28 Very High Very High Very High
Hippocampus 10 80.52 Quite High
beta blocker 13 74.36 Quite High
ischemia 9 40.48 Quite Low
cytokine 3 38.48 Quite Low
Neurotransmitter 8 5.00 Very Low Very Low Very Low
dexamethasone 3 5.00 Very Low Very Low Very Low
gABA 2 5.00 Very Low Very Low Very Low
tetrodotoxin 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cv General 4 Under Development 41 99.88 Very High Very High Very High
Coronary Artery Disease 4 71.76 Quite High
Heart Rate Under Development 18 71.64 Quite High
Stress 14 69.40 Quite High
Left Ventricular Dysfunction 6 67.16 Quite High
Cv General 3 Under Development 10 43.84 Quite Low
Stroke 22 10.56 Low Low
Neurodegenerative Disease 7 5.00 Very Low Very Low Very Low
Cv Unclassified Under Development 7 5.00 Very Low Very Low Very Low
Neurological Disease 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
While no behavioral recovery was noted in PBS injected control animals, ICH mice grafted with B10 cells showed a significant improvement in motor performance from 8 days post-transplantation and the improvement lasted for up to 7 weeks post-transplantation as compared with controls by one-way ANOVA (8 days p?
B10 Binding (grafted) of associated with cva
1) Confidence 0.06 Published 2007 Journal PLoS ONE Section Body Doc Link PMC2092394 Disease Relevance 0.34 Pain Relevance 0.24
The inotropic effect of both enoximone and dobutamine is obtained via the same final biochemical pathway (an increase in intracellular cyclic adenosine monophospate) but by means of different mechanisms: enoximone acts distally to the beta-adrenoceptor, and binds directly and selectively to the intracellular enzyme phosphodiesterase III that specifically degrades cardiac cyclic adenosine monophosphate.
phosphodiesterase III Binding (binds) of associated with adenocard
2) Confidence 0.04 Published 2003 Journal Cardiovasc Ultrasound Section Body Doc Link PMC240109 Disease Relevance 0.40 Pain Relevance 0.14

General Comments

This test has worked.

Personal tools